sb 203580 has been researched along with whi p180 in 3 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (whi p180) | Trials (whi p180) | Recent Studies (post-2010) (whi p180) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 15 | 0 | 8 |
| Protein | Taxonomy | sb 203580 (IC50) | whi p180 (IC50) |
|---|---|---|---|
| Chain A, CYCLIN-DEPENDENT KINASE 2 | Homo sapiens (human) | 1 | |
| Chain A, P38 KINASE | Homo sapiens (human) | 1 | |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | 0.1922 | |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | 0.125 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.1625 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 1 | |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | Homo sapiens (human) | 0.002 | |
| Ephrin type-B receptor 2 | Homo sapiens (human) | 1.2 | |
| Kinesin-1 heavy chain | Homo sapiens (human) | 0.38 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.1787 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.05 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, JR; Deretey, E; Foster, JE; Ng, W; Pasternak, A; Redden, PR; Reid, N; Slon-Usakiewicz, JJ; Toledo-Sherman, L | 1 |
| Dai, JR; Deretey, E; Foster, JE; Liao, LC; Ng, W; Pasternak, A; Redden, PR; Reid, N; Slon-Usakiewicz, JJ; Toledo-Sherman, L; Uger, MD | 1 |
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
3 other study(ies) available for sb 203580 and whi p180
| Article | Year |
|---|---|
Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA.
Topics: Chromatography, Affinity; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Ligands; Mass Spectrometry; Models, Molecular; Receptor, EphB2 | 2004 |
Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Chromatography, Affinity; Databases, Factual; Enzyme-Linked Immunosorbent Assay; Heterocyclic Compounds; Humans; Mass Spectrometry; Models, Molecular; Molecular Weight; Naphthoquinones; Phosphorylation; Protein Structure, Tertiary; Quantitative Structure-Activity Relationship; Receptor, EphB2; Sulfides | 2005 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |